Ardent Health Inc. Reports 11.9% Increase in Total Revenue and 38.9% Growth in Adjusted EBITDA for 2Q25

Reuters

Aug 06

Ardent Health Inc. Reports 11.9% Increase in Total Revenue and 38.9% Growth in Adjusted EBITDA for 2Q25

Ardent Health Inc. has released its second quarter 2025 financial results, reporting a significant year-over-year increase in total revenue and adjusted EBITDA. Total revenue for the quarter reached $1.65 billion, marking an 11.9% growth compared to $1.47 billion in the same period last year. Adjusted EBITDA also saw a substantial rise of 38.9%, increasing from $122.3 million in the second quarter of 2024 to $169.9 million in the current quarter. Moreover, Ardent Health reported an expansion in its adjusted EBITDA margin, which grew by 200 basis points from 8.3% to 10.3%. The company experienced strong admissions growth, with a 6.6% year-over-year increase. Adjusted admissions rose 1.6% in the second quarter and have grown 2.2% year-to-date for 2025. The financial performance of Ardent Health indicates robust growth and improved operational efficiency compared to the previous year.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ardent Health Inc. published the original content used to generate this news brief on August 06, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2557312560"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2557312560\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2557312560?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-06 05:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2557312560","market":"nz","top_or_hot":-1,"title":"Ardent Health Inc. Reports 11.9% Increase in Total Revenue and 38.9% Growth in Adjusted EBITDA for 2Q25","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Ardent Health Inc. Reports 11.9% Increase in Total Revenue and 38.9% Growth in Adjusted EBITDA for 2Q25\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Ardent Health Inc. has released its second quarter 2025 financial results, reporting a significant year-over-year increase in total revenue and adjusted EBITDA. Total revenue for the quarter reached $1.65 billion, marking an 11.9% growth compared to $1.47 billion in the same period last year. Adjusted EBITDA also saw a substantial rise of 38.9%, increasing from $122.3 million in the second quarter of 2024 to $169.9 million in the current quarter. Moreover, Ardent Health reported an expansion in its adjusted EBITDA margin, which grew by 200 basis points from 8.3% to 10.3%. The company experienced strong admissions growth, with a 6.6% year-over-year increase. Adjusted admissions rose 1.6% in the second quarter and have grown 2.2% year-to-date for 2025. The financial performance of Ardent Health indicates robust growth and improved operational efficiency compared to the previous year.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ardent Health Inc. published the original content used to generate this news brief on August 06, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ardent Health Inc. Reports 11.9% Increase in Total Revenue and 38.9% Growth in Adjusted EBITDA for 2Q25</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nArdent Health Inc. Reports 11.9% Increase in Total Revenue and 38.9% Growth in Adjusted EBITDA for 2Q25\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-08-06 05:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Ardent Health Inc. Reports 11.9% Increase in Total Revenue and 38.9% Growth in Adjusted EBITDA for 2Q25\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Ardent Health Inc. has released its second quarter 2025 financial results, reporting a significant year-over-year increase in total revenue and adjusted EBITDA. Total revenue for the quarter reached $1.65 billion, marking an 11.9% growth compared to $1.47 billion in the same period last year. Adjusted EBITDA also saw a substantial rise of 38.9%, increasing from $122.3 million in the second quarter of 2024 to $169.9 million in the current quarter. Moreover, Ardent Health reported an expansion in its adjusted EBITDA margin, which grew by 200 basis points from 8.3% to 10.3%. The company experienced strong admissions growth, with a 6.6% year-over-year increase. Adjusted admissions rose 1.6% in the second quarter and have grown 2.2% year-to-date for 2025. The financial performance of Ardent Health indicates robust growth and improved operational efficiency compared to the previous year.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ardent Health Inc. published the original content used to generate this news brief on August 06, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ARDT","symbol_name":"Ardent Health Partners (2024 New Filing)","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250805:nNDL1XF8FH:1","article_id":"2557312560","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2557312560","pubTimestamp":1754428164,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Ardent Health Inc. has released its second quarter 2025 financial results, reporting a significant year-over-year increase in total revenue and adjusted EBITDA. Total revenue for the quarter reached $1.65 billion, marking an 11.9% growth compared to $1.47 billion in the same period last year. Adjusted EBITDA also saw a substantial rise of 38.9%, increasing from $122.3 million in the second quarter of 2024 to $169.9 million in the current quarter. Moreover, Ardent Health reported an expansion in its adjusted EBITDA margin, which grew by 200 basis points from 8.3% to 10.3%. The company experienced strong admissions growth, with a 6.6% year-over-year increase. Adjusted admissions rose 1.6% in the second quarter and have grown 2.2% year-to-date for 2025. The financial performance of Ardent Health indicates robust growth and improved operational efficiency compared to the previous year.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"ARDT":"Ardent Health Partners (2024 New Filing)"},"translate_title":"Ardent Health Inc.报告2025年第二季度总收入增长11.9%，调整后EBITDA增长38.9%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ARDT":0.9},"content_text":"Ardent Health Inc. Reports 11.9% Increase in Total Revenue and 38.9% Growth in Adjusted EBITDA for 2Q25\n    \n\n        Ardent Health Inc. has released its second quarter 2025 financial results, reporting a significant year-over-year increase in total revenue and adjusted EBITDA. Total revenue for the quarter reached $1.65 billion, marking an 11.9% growth compared to $1.47 billion in the same period last year. Adjusted EBITDA also saw a substantial rise of 38.9%, increasing from $122.3 million in the second quarter of 2024 to $169.9 million in the current quarter. Moreover, Ardent Health reported an expansion in its adjusted EBITDA margin, which grew by 200 basis points from 8.3% to 10.3%. The company experienced strong admissions growth, with a 6.6% year-over-year increase. Adjusted admissions rose 1.6% in the second quarter and have grown 2.2% year-to-date for 2025. The financial performance of Ardent Health indicates robust growth and improved operational efficiency compared to the previous year.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ardent Health Inc. published the original content used to generate this news brief on August 06, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}